Stay updated on Vactosertib With Pembrolizumab in Colorectal/Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Vactosertib With Pembrolizumab in Colorectal/Gastric Cancer Clinical Trial page.

Latest updates to the Vactosertib With Pembrolizumab in Colorectal/Gastric Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page now shows Revision: v3.0.2 (replacing v3.0.1), and the 'Back to Top' element has been removed.SummaryDifference0.2%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.2%
- Check17 days agoChange DetectedThe web page has undergone significant updates, including the addition of specific facility names and locations in South Korea, as well as new medical topics related to colorectal and intestinal diseases. Notably, the drug vactosertib has been included, while previous references to Pembrolizumab and various cancer-related topics have been removed.SummaryDifference3%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated to version 2.16.11, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.9%
- Check52 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and now includes information about the HHS Vulnerability Disclosure.SummaryDifference0.2%
Stay in the know with updates to Vactosertib With Pembrolizumab in Colorectal/Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vactosertib With Pembrolizumab in Colorectal/Gastric Cancer Clinical Trial page.